Germany · Delayed Price · Currency is EUR Eckert & Ziegler SE Company Description
Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally.
It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds based on iodine-125; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of choroidal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services.
It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration-related sources for radioisotopes.
In addition, the company offers Tc-99m generators and supplies, trade in raw isotopes and other products, and services.
It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024.
Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany.
| Country | Germany |
| Founded | 1992 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,116 |
| CEO | Harald Hasselmann |
Contact Details
Address: Robert-Rössle-Straße 10 Berlin, 13125 Germany | |
| Phone | 49 30 94 10 84 0 |
| Website | ezag.com |
Stock Details
| Ticker Symbol | EUZ |
| Exchange | Deutsche Börse Xetra |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | DE0005659700 |
| SIC Code | 2810 |
Key Executives
| Name | Position |
|---|---|
| Dr. Harald Hasselmann | Chief Executive Officer and Chairman of the Executive Board of Medical Segment |
| Dr. Gunnar Mann | Chief Operating Officer and Member of the Executive Board |
| Karolin Riehle | Head of Investor Relations and PR |
| Joseph Hathcock | Chief Operating Officer of Segment Isotope Products |
| Julian Schröder | Head of Group Controlling |
| Ivan Simmer | Managing Director of Eckert and Ziegler Cesio s.r.o. |